Artificial intelligence-assisted analysis of efficacy, safety, and efficiency of pegylated factor VIII concentrates in hemophilia A based on product inserts
Revista Hemostasia y Trombosis · 30.10.2026 · 2 (1)
DOI: 10.24875/rht.m25000036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Hemostasia y Trombosis, online erschienen am 30.10.2026. Verfasst von Manuel Rodríguez-López und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rodríguez-López, M., Calviño-Suárez, M., Núñez-Vázquez, R. J., & Ocampo-Martínez, R. (2026). Artificial intelligence-assisted analysis of efficacy, safety, and efficiency of pegylated factor VIII concentrates in hemophilia A based on product inserts. Revista Hemostasia y Trombosis, 2(1). https://doi.org/10.24875/rht.m25000036
Vancouver
Rodríguez-López M, Calviño-Suárez M, Núñez-Vázquez RJ, Ocampo-Martínez R. Artificial intelligence-assisted analysis of efficacy, safety, and efficiency of pegylated factor VIII concentrates in hemophilia A based on product inserts. Revista Hemostasia y Trombosis. 2026;2(1). doi:10.24875/rht.m25000036
BibTeX
@article{RodrguezLpez2026,
author = {Rodríguez-López, Manuel and Calviño-Suárez, Michael and Núñez-Vázquez, Ramiro J. and Ocampo-Martínez, Raquel},
title = {Artificial intelligence-assisted analysis of efficacy, safety, and efficiency of pegylated factor VIII concentrates in hemophilia A based on product inserts},
journal = {Revista Hemostasia y Trombosis},
year = {2026},
volume = {2},
number = {1},
doi = {10.24875/rht.m25000036}
}
EUVIMED